Saura C, Oliveira M, Feng YH, Dai MS, et al. Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With >/= 2 HER2-Directed Regimens: Phase III NALA Trial. J Clin Oncol 2020 Jul 17:JCO2000147. doi: 10.1200/JCO.20.00147.
PMID: 32678716